Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop

1. Novo Nordisk's shares rose 2% after last week's significant decline. 2. The company cut its full-year outlook and appointed a new CEO. 3. Analysts downgraded Novo Nordisk due to competitive pressure from Eli Lilly. 4. Key support levels are around $36 and $29; resistance at $60 and $78. 5. Technical indicators signal potential short-term recoveries but long-term bearishness.